Nana Tchabo

962 total citations
25 papers, 744 citations indexed

About

Nana Tchabo is a scholar working on Molecular Biology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Nana Tchabo has authored 25 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Obstetrics and Gynecology and 8 papers in Reproductive Medicine. Recurrent topics in Nana Tchabo's work include Ovarian cancer diagnosis and treatment (7 papers), Uterine Myomas and Treatments (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Nana Tchabo is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Uterine Myomas and Treatments (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Nana Tchabo collaborates with scholars based in United States, Australia and Belgium. Nana Tchabo's co-authors include Kunle Odunsi, Shashikant Lele, Paulette Mhawech‐Fauceglia, Jianqun Liao, Amy Beck, Wendy J. Huss, Carl Morrison, Xinhui Wang, Feng Qian and Elise C. Kohn and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Nana Tchabo

23 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nana Tchabo United States 14 326 235 204 190 133 25 744
Satoshi Tsunetoh Japan 15 280 0.9× 243 1.0× 235 1.2× 159 0.8× 188 1.4× 32 715
Yoshimichi Tanaka Japan 16 350 1.1× 269 1.1× 280 1.4× 194 1.0× 198 1.5× 45 850
Satoe Fujiwara Japan 14 279 0.9× 227 1.0× 210 1.0× 169 0.9× 168 1.3× 38 677
Masanori Kanemura Japan 18 415 1.3× 309 1.3× 269 1.3× 193 1.0× 171 1.3× 37 920
Yasuhisa Terao Japan 15 408 1.3× 317 1.3× 221 1.1× 138 0.7× 226 1.7× 74 953
Mark E. Borowsky United States 13 339 1.0× 329 1.4× 250 1.2× 103 0.5× 165 1.2× 24 896
Dilu Feng China 14 370 1.1× 180 0.8× 113 0.6× 219 1.2× 84 0.6× 26 649
Julian A. Gingold United States 17 702 2.2× 244 1.0× 258 1.3× 293 1.5× 167 1.3× 60 1.3k
Andrew N. Stephens Australia 17 304 0.9× 342 1.5× 339 1.7× 162 0.9× 104 0.8× 32 892
Mingzi Tan China 16 339 1.0× 125 0.5× 145 0.7× 176 0.9× 57 0.4× 28 615

Countries citing papers authored by Nana Tchabo

Since Specialization
Citations

This map shows the geographic impact of Nana Tchabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nana Tchabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nana Tchabo more than expected).

Fields of papers citing papers by Nana Tchabo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nana Tchabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nana Tchabo. The network helps show where Nana Tchabo may publish in the future.

Co-authorship network of co-authors of Nana Tchabo

This figure shows the co-authorship network connecting the top 25 collaborators of Nana Tchabo. A scholar is included among the top collaborators of Nana Tchabo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nana Tchabo. Nana Tchabo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tchabo, Nana, et al.. (2025). Indication for diagnostic oophorectomy without radiographic evidence: two cases of postmenopausal androgen-secreting ovarian hyperplasia. Menopause The Journal of The North American Menopause Society. 32(11). 1072–1076.
2.
Tchabo, Nana, et al.. (2022). Retroperitoneal primary adenocarcinoma of Mullerian origin: case report with radiology review. SHILAP Revista de lepidopterología. 17(10). 3810–3815.
3.
Tchabo, Nana, et al.. (2020). Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation. Obstetrics and Gynecology. 135(6). 1270–1274. 6 indexed citations
4.
Capaccione, Kathleen M., et al.. (2017). Massive endometrioma presenting with dyspnea and abdominal symptoms. Radiology Case Reports. 12(4). 741–745. 2 indexed citations
5.
Gray, Heidi J., Benedict B. Benigno, Jonathan S. Berek, et al.. (2016). Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial. Journal for ImmunoTherapy of Cancer. 4(1). 34–34. 36 indexed citations
6.
Hughes, Patrick, Daniel H. Tobias, Nana Tchabo, et al.. (2014). Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC). Gynecologic Oncology. 135(2). 196–200. 22 indexed citations
7.
Aziz, Michael M., Paul B. Heller, Nana Tchabo, et al.. (2014). Incidental power morcellation of malignancy: A retrospective cohort study. Gynecologic Oncology. 136(2). 274–277. 47 indexed citations
8.
Liao, Jianqun, Feng Qian, Nana Tchabo, et al.. (2014). Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism. PLoS ONE. 9(1). e84941–e84941. 290 indexed citations
9.
Tchabo, Nana, et al.. (2014). Analyzing the learning curve of robotic-assisted sentinel lymph node dissection for endometrial cancer. Gynecologic Oncology. 133. 130–130. 1 indexed citations
10.
Tchabo, Nana, et al.. (2014). Does ultrastaging improve detection of micrometastasis for early-stage endometrial cancer?. Gynecologic Oncology. 133. 130–131. 1 indexed citations
11.
Mhawech‐Fauceglia, Paulette, François R. Herrmann, Nana Tchabo, et al.. (2010). IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid Adenocarcinoma. American Journal of Clinical Pathology. 133(6). 899–908. 31 indexed citations
12.
13.
Tchabo, Nana, Susan A. McCloskey, Terry Mashtare, et al.. (2009). Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992–2006. Gynecologic Oncology. 115(2). 249–256. 12 indexed citations
14.
McCloskey, Susan A., Nana Tchabo, H Malhotra, et al.. (2009). Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecologic Oncology. 116(3). 404–407. 28 indexed citations
15.
Simpkins, Fiona, Nick Devoogdt, Nabila Rasool, et al.. (2007). The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells. Carcinogenesis. 29(3). 466–472. 38 indexed citations
16.
Posadas, Edwin M., Virginia E. Kwitkowski, Herbert L. Kotz, et al.. (2007). A prospective analysis of imatinib‐induced c‐kit modulation in ovarian cancer. Cancer. 110(2). 309–317. 53 indexed citations
17.
Tchabo, Nana, et al.. (2005). Applying Proteomics in Clinical Trials. PubMed. 5(3). 141–148. 15 indexed citations
18.
Tchabo, Nana, Stephen R. Grobmyer, William R. Jarnagin, & D.S. Chi. (2005). Conservative management of pneumatosis intestinalis. Gynecologic Oncology. 99(3). 782–784. 18 indexed citations
19.
Simpkins, Fiona, et al.. (2005). The role of the secretory leukocyte protease inhibitor (SLPI) and granulin epithelin precursor (GEP) axis in ovarian cancer. 65. 186–186. 1 indexed citations
20.
Tchabo, Nana, Elizabeth A. Guancial, Josephine A. Czechowicz, & Elise C. Kohn. (2005). The Role of Proteomics in the Diagnosis and Treatment of Ovarian Cancer. Women s Health. 1(3). 365–374. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026